Document is current
Any future updates will be listed below
-
Authors
Bevilacqua, Gregorio https://orcid.org/0000-0001-7819-1482
Westbury, Leo D.
Bloom, Ilse https://orcid.org/0000-0002-4893-1790
Zhang, Jean
Ward, Kate A. https://orcid.org/0000-0001-7034-6750
Cooper, Cyrus https://orcid.org/0000-0003-3510-0709
Dennison, Elaine M. https://orcid.org/0000-0002-3048-4961
-
Funding
Funding for this research was provided by:
Medical Research Council (MC_PC_21001, MC_UU_12011/5, ES/L002663/1)
National Institute for Health Research Southampton Biomedical Research Centre
- License Information
-
More Information
Article History
Received: 30 September 2022
Accepted: 5 December 2022
First Online: 19 December 2022
Declarations
:
: CC has received lecture fees and honoraria from Amgen, Danone, Eli Lilly, GSK, Kyowa Kirin, Medtronic, Merck, Nestlé, Novartis, Pfizer, Roche, Servier, Shire, Takeda and UCB outside of the submitted work. EMD has received speaker honoraria from UCB, Pfizer, Lilly and Viatris. GB, LDW, IB, JZ, and KAW have no relevant interests to declare.
: Ethical approval for work conducted in HCS was granted by the East of England—Cambridgeshire and Hertfordshire Research Ethics Committee, reference number 11/EE/0196. All participants provided informed consent prior to participation in this study. All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
